Evidence map›Paper›PMID 34738218›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2022

A Case-Control Study of Follicular Fluid Cytokine Profiles in Women with Diminished Ovarian Reserve.

Sina Abhari, Jingqiao Lu, Heather S Hipp, Brianne Petritis, Sabrina A Gerkowicz, Quinton S Katler, Haw-Han Yen, Yingqing Mao, Hao Tang, Weirong Shang and 4 more

Open access · greenAbstract read
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Sina AbhariDepartment of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility, Emory University School of Medicine, 550 Peachtree Street, NE Suite 1800, Atlanta, GA, 30308, USA.
Jingqiao LuRayBiotech Life, Inc, 3607 Parkway Lane, Peachtree Corners, GA, 30092, USA.
Heather S HippDepartment of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility, Emory University School of Medicine, 550 Peachtree Street, NE Suite 1800, Atlanta, GA, 30308, USA.
Brianne PetritisRayBiotech Life, Inc, 3607 Parkway Lane, Peachtree Corners, GA, 30092, USA.
Sabrina A GerkowiczIVF MD, 9960 Central Park Boulevard, Boca Raton, FL, 33428, USA.
Quinton S KatlerDepartment of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility, Emory University School of Medicine, 550 Peachtree Street, NE Suite 1800, Atlanta, GA, 30308, USA.
Haw-Han YenRayBiotech Life, Inc, 3607 Parkway Lane, Peachtree Corners, GA, 30092, USA.
Yingqing MaoRayBiotech Life, Inc, 3607 Parkway Lane, Peachtree Corners, GA, 30092, USA.
Hao TangRayBiotech Life, Inc, 3607 Parkway Lane, Peachtree Corners, GA, 30092, USA.
Weirong ShangDepartment of Gynecology and Obstetrics, Division of Reproductive Endocrinology and Infertility, Emory University School of Medicine, 550 Peachtree Street, NE Suite 1800, Atlanta, GA, 30308, USA.
Laurie J McKenzieDivision of Reproductive Endocrinology and Infertility, Baylor College of Medicine, Houston, TX, USA.
Alicia K SmithDepartment of Gynecology and Obstetrics, Division of Research, Emory University School of Medicine, Woodruff Memorial Research Building, Atlanta, GA, 30322, USA.
Ruo-Pan Huang *RayBiotech Life, Inc, 3607 Parkway Lane, Peachtree Corners, GA, 30092, USA.
Anna K Knight *Department of Gynecology and Obstetrics, Division of Research, Emory University School of Medicine, Woodruff Memorial Research Building, Atlanta, GA, 30322, USA. anna.knight@emory.edu.
Emory University · USRayBiotech (United States) · USBaylor College of Medicine · US

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Neuro HPA Project 1U54AG062334 · NIA · EMORY UNIVERSITY · PI Ighovwerha Ofotokun · 2018 to 2026
$12.2M
Emory University BIRCWH ProgramK12HD085850 · NICHD · EMORY UNIVERSITY · PI OFOTOKUN, IGHOVWERHA, STERK, CLAIRE E · 2015 to 2023
$4.4M
Emory University BIRCWH ProgramK12AR084234 · NIAMS · EMORY UNIVERSITY · PI Vasiliki Michopoulos, CLAIRE E STERK · 2024 to 2026
$2.6M
NCATS NIH HHS UL1 TR002378NIAMS NIH HHS K12 AR084234NIA NIH HHS U54 AG062334NICHD NIH HHS K12 HD085850NIH HHS K12HD085850NIH HHS UL1TR002378
6 · The paper itself

Abstract

Ovarian reserve is an important determinant of a woman's reproductive potential, and women with diminished ovarian reserve (DOR) often seek in vitro fertilization (IVF). The underlying etiology of DOR is unknown, but follicular fluid cytokine concentrations likely play a role in follicular development and maturation. The present study seeks to investigate the expression of cytokines in follicular fluid (FF) of women with DOR undergoing IVF and explore correlated functional pathways. One hundred ninety-four women undergoing ovarian stimulation were recruited at the time of oocyte retrieval. Women were classified as having DOR if they met one or more of the following criteria: AMH < 1 ng/ml, FSH > 10 mIU/ml, and/or AFC < 10. Controls included women undergoing IVF for male factor, tubal factor due to tubal ligation, or planned oocyte cryopreservation (non-oncologic). The concentrations of 480 cytokines and related growth factors in follicular fluid were determined using a multiplex immunoassay. Fifty-nine cytokines had significantly different concentrations (53 higher and 6 lower) in the DOR relative to the control group after adjusting for age and body mass index (BMI) (false discovery rate; FDR < 0.1). Using the most informative 44 biomarkers as indicated by a random forest (RF) model, an area under the curve (AUC) of 0.78 was obtained. Thus, follicular microenvironment differs between women with DOR and normal ovarian reserve. The differentially expressed cytokines belong to diverse processes that are primarily involved in follicular maturation and ovulation. These changes may play an important role in treatment outcomes in women with DOR.

Indexed as

Ovarian DiseasesOvarian ReserveAnti-Mullerian HormoneCase-Control StudiesCytokinesFemaleFertilization in VitroFollicular FluidHumansMaleOvulation InductionAnti-Mullerian HormoneCytokinesCytokinesDiminished ovarian reserveFollicular fluidIn vitro fertilization

Identifiers

PMID34738218
PMCPMC10201686
OpenAlexW3208853233

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.